Coronavirus Update: CMS Grants Blanket Exceptions and Extensions Across Its Quality Measurement Programs

March 22, 2020

In response to the novel coronavirus (COVID-19) outbreak, the Centers for Medicare & Medicaid Services (CMS) announced today it is granting a range of data reporting exceptions and extensions across its quality reporting and value-based payment programs for hospitals, post-acute care facilities and clinicians. Specifically:

  • CMS is making it optional to submit data from the 4th quarter of 2019 (October through December), as well as the first two quarters of 2020 (January through March, and April through June); and
  • CMS will not use data from Jan. 1, 2020 through June 30, 2020 to calculate performance in its quality reporting and value-based purchasing programs.

CMS indicates these policy changes are intended to relieve provider data reporting burden during this emergency, and to ensure it does not tie provider performance or payment to a time period that does not represent their true quality performance. CMS says it will continue to monitor the impact of the situation and assess additional options for providing relief.

CMS’s specific quality measurement program exception and extension policies are outlined in the tables below.

If you have further questions, please contact Akin Demehin, AHA director of policy, at ademehin@aha.org.

Related Resources

Case Studies
Riley Children’s Health is working to ensure that children, including those under age 5, get the COVID-19 vaccine, by hosting vaccine clinics across the…
Case Studies
While masks have been removed from most school supply lists this season, health care officials say new variants, such as BA.5, can spread quickly putting kids…
Guides/Reports
Public
At the outset of the COVID-19 pandemic, communities across America entered mandatory quarantines and temporarily shut down many every day services such as…
Case Studies
To encourage Arkansas residents of all ages to get the COVID-19 vaccine and booster, Baptist Health has set up vaccine clinics across the state at banks,…
Advancing Health Podcast
Public
As we start to emerge from the COVID-19 pandemic, understanding and reconnecting to purpose, rediscovering our why is key to moving forward.
Guides/Reports
Member
What is Paxlovid? Paxlovid (ritonavir-boosted nirmatrelvir) is a preferred oral antiviral authorized for the treatment of mild-moderate COVID-19 illness.…